EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Acetylation: a new target for protein degradation in cancer

Callie E W Crawford, George M Burslem

Trends in Cancer · 2025

DOI: 10.1016/j.trecan.2025.01.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025. Verfasst von Callie E W Crawford und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, PA 19104, USA. Hauptthemen laut MEDLINE: Neoplasms, Proteolysis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetylation is an increasing area of focus for cancer research as it is closely related to a variety of cellular processes through modulation of histone and non-histone proteins. However, broadly targeting acetylation threatens to yield nonselective toxic effects owing to the vital role of acetylation in cellular function. There is thus a pressing need to elucidate and characterize the specific cancer-relevant roles of acetylation for future therapeutic design. Acetylation-mediated protein homeostasis is an example of selective acetylation that affects a myriad of proteins as well as their correlated functions. We review recent examples of acetylation-mediated protein homeostasis that have emerged as key contributors to tumorigenesis, tumor proliferation, metastasis, and/or drug resistance, and we discuss their implications for future exploration of this intriguing phenomenon.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsProteolysisHumansAcetylationAnimalsDrug Resistance, NeoplasmAntineoplastic AgentsProtein Processing, Post-TranslationalCell ProliferationCarcinogenesisHistones

Stichwörter der Autor:innen

acetylationcancerdegradationheterobifunctionalubiquitination

Substanzen

Antineoplastic AgentsHistones

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, PA 19104, USA.
  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, PA 19104, USA; Department of Cancer Biology and Epigenetics Institute, Perelman School of Medicine, University of Penns…

Förderung

  • NIGMS NIH HHS
  • NIH National Institute of General Medical Sciences

Zitieren

APA

Crawford, C. E. W., & Burslem, G. M. (2025). Acetylation: a new target for protein degradation in cancer. Trends in Cancer. https://doi.org/10.1016/j.trecan.2025.01.013

Vancouver

Crawford CEW, Burslem GM. Acetylation: a new target for protein degradation in cancer. Trends in Cancer. 2025. doi:10.1016/j.trecan.2025.01.013

BibTeX
@article{Crawford2025,
  author = {Crawford, Callie E W and Burslem, George M},
  title = {Acetylation: a new target for protein degradation in cancer},
  journal = {Trends in Cancer},
  year = {2025},
  doi = {10.1016/j.trecan.2025.01.013}
}
Kostenlos starten →